Skip to main content

Table 1 Tocotrienol intake and risk of breast cancer-specific death/recurrence in women with early breast cancer and estrogen receptor--positive tumors receiving tamoxifen

From: Tocotrienols and breast cancer: the evidence to date

Outcome

Received tocotrienol

Relative risk (95% CI)

Absolute risk reduction (95% CI)

Numbers needed to treat

Yes

No

n = 120% (Number)

n = 120% (Number)

Primary end point

 Breast cancer related death

0.017 (2)

0.050 (6)

0.33 (0.07–1.62)

−0.03 (−0.09 to 0.02)

30

Secondary end point

 Recurrence

0.133 (16)

0.167 (20)

0.80 (0.44–1.47)

−0.03 (−0.13 to 0.06)

30